Zack Pemberton-Whiteley

Zack currently leads Patient Advocacy at Autolus Therapeutics collaborating with the patient community across the company.

Prior to this Zack was Executive Director Patient Engagement for Novartis at a global level, leading their Centre of Excellence team.

Before joining industry, Zack previously worked in non-profits and patient advocacy, most recently as Chief Executive Officer of Leukaemia Care in the UK. Alongside this he was Founder and Chair of the global Acute Leukemia Advocates Network (ALAN), Chair of the Blood Cancer Alliance (UK) and Vice-Chair of the European Hematology Association Patient Advocacy Committee (EHA PAC).